DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 32 filers reported holding DEXCOM INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,337,030 | -25.4% | 1,035,000 | +3.1% | 0.00% | -25.0% |
| Q2 2023 | $3,130,974 | -39.9% | 1,004,000 | -46.9% | 0.00% | -50.0% |
| Q4 2022 | $5,210,568 | -100.0% | 1,892,000 | -53.4% | 0.01% | -52.9% |
| Q1 2022 | $12,619,230,000 | -51.4% | 4,056,000 | -59.4% | 0.02% | -50.0% |
| Q2 2021 | $25,987,500,000 | +106.8% | 10,000,000 | +75.4% | 0.03% | +88.9% |
| Q1 2021 | $12,563,579,000 | -84.6% | 5,701,000 | -84.1% | 0.02% | -88.2% |
| Q4 2020 | $81,638,873,000 | -2.3% | 35,907,000 | +8.6% | 0.15% | +26.7% |
| Q3 2020 | $83,560,771,000 | +61.8% | 33,077,000 | +58.9% | 0.12% | +31.9% |
| Q2 2020 | $51,642,796,000 | +344.1% | 20,818,000 | +213.0% | 0.09% | +279.2% |
| Q1 2020 | $11,628,694,000 | -51.7% | 6,652,000 | -59.1% | 0.02% | -45.5% |
| Q4 2019 | $24,078,387,000 | – | 16,256,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |